CD19 (CD19 molecule)

2003-11-01  

Identity

HGNC
LOCATION
16p11.2
LOCUSID
ALIAS
B4,CVID3
FUSION GENES

Other Information

Locus ID:

NCBI: 930
MIM: 107265
HGNC: 1633
Ensembl: ENSG00000177455

Variants:

dbSNP: 930
ClinVar: 930
TCGA: ENSG00000177455
COSMIC: CD19

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000177455ENST00000324662P15391
ENSG00000177455ENST00000538922P15391

Expression (GTEx)

0
50
100
150
200

Pathways

PathwaySourceExternal ID
Hematopoietic cell lineageKEGGko04640
B cell receptor signaling pathwayKEGGko04662
Primary immunodeficiencyKEGGko05340
Hematopoietic cell lineageKEGGhsa04640
B cell receptor signaling pathwayKEGGhsa04662
Primary immunodeficiencyKEGGhsa05340
Epstein-Barr virus infectionKEGGhsa05169
Epstein-Barr virus infectionKEGGko05169
PI3K-Akt signaling pathwayKEGGhsa04151
PI3K-Akt signaling pathwayKEGGko04151
DiseaseREACTOMER-HSA-1643685
Diseases of signal transductionREACTOMER-HSA-5663202
PI3K/AKT Signaling in CancerREACTOMER-HSA-2219528
Constitutive Signaling by Aberrant PI3K in CancerREACTOMER-HSA-2219530
Immune SystemREACTOMER-HSA-168256
Adaptive Immune SystemREACTOMER-HSA-1280218
Signaling by the B Cell Receptor (BCR)REACTOMER-HSA-983705
Antigen activates B Cell Receptor (BCR) leading to generation of second messengersREACTOMER-HSA-983695
Downstream signaling events of B Cell Receptor (BCR)REACTOMER-HSA-1168372
PIP3 activates AKT signalingREACTOMER-HSA-1257604
Negative regulation of the PI3K/AKT networkREACTOMER-HSA-199418
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cellREACTOMER-HSA-198933
Innate Immune SystemREACTOMER-HSA-168249
DAP12 interactionsREACTOMER-HSA-2172127
DAP12 signalingREACTOMER-HSA-2424491
Fc epsilon receptor (FCERI) signalingREACTOMER-HSA-2454202
Role of LAT2/NTAL/LAB on calcium mobilizationREACTOMER-HSA-2730905
Signal TransductionREACTOMER-HSA-162582
Signaling by EGFRREACTOMER-HSA-177929
GAB1 signalosomeREACTOMER-HSA-180292
Signalling by NGFREACTOMER-HSA-166520
NGF signalling via TRKA from the plasma membraneREACTOMER-HSA-187037
PI3K/AKT activationREACTOMER-HSA-198203
Signaling by PDGFREACTOMER-HSA-186797
Downstream signal transductionREACTOMER-HSA-186763
Signaling by SCF-KITREACTOMER-HSA-1433557
PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingREACTOMER-HSA-6811558

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
166727012006An antibody-deficiency syndrome due to mutations in the CD19 gene.127
195615392009Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor.124
202374082010CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.102
255739862015A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow.42
123877432002The physiologic role of CD19 cytoplasmic tyrosines.41
163528042006Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.41
213485732011Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.38
178822242007Novel mutations in a Japanese patient with CD19 deficiency.37
294007102018A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects.37
173274052007CD38/CD19: a lipid raft-dependent signaling complex in human B cells.36

Citation

Dessen P

CD19 (CD19 molecule)

Atlas Genet Cytogenet Oncol Haematol. 2003-11-01

Online version: http://atlasgeneticsoncology.org/gene/969/cd19